BRACONI, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 9.642
EU - Europa 7.965
AS - Asia 3.823
SA - Sud America 642
Continente sconosciuto - Info sul continente non disponibili 263
AF - Africa 194
OC - Oceania 16
Totale 22.545
Nazione #
US - Stati Uniti d'America 9.511
GB - Regno Unito 1.954
IT - Italia 1.519
RU - Federazione Russa 1.296
SG - Singapore 1.224
CN - Cina 1.223
IE - Irlanda 794
DE - Germania 566
BR - Brasile 538
SE - Svezia 488
UA - Ucraina 429
VN - Vietnam 405
FR - Francia 395
HK - Hong Kong 274
FI - Finlandia 194
KR - Corea 174
IN - India 145
ZA - Sudafrica 76
BD - Bangladesh 71
CA - Canada 65
TR - Turchia 65
ES - Italia 64
AR - Argentina 48
BE - Belgio 42
CI - Costa d'Avorio 39
NL - Olanda 39
PL - Polonia 35
MX - Messico 34
CZ - Repubblica Ceca 33
NG - Nigeria 31
JP - Giappone 30
IQ - Iraq 29
PK - Pakistan 25
IR - Iran 24
ID - Indonesia 23
AT - Austria 22
PT - Portogallo 15
AE - Emirati Arabi Uniti 13
EE - Estonia 12
LT - Lituania 12
AU - Australia 11
EC - Ecuador 11
JO - Giordania 11
KE - Kenya 11
VE - Venezuela 11
CH - Svizzera 10
CO - Colombia 10
UZ - Uzbekistan 10
AZ - Azerbaigian 9
CR - Costa Rica 9
SA - Arabia Saudita 9
TN - Tunisia 9
BO - Bolivia 8
EG - Egitto 8
SK - Slovacchia (Repubblica Slovacca) 8
EU - Europa 7
PH - Filippine 7
JM - Giamaica 6
MA - Marocco 6
NP - Nepal 6
PY - Paraguay 6
TH - Thailandia 6
AL - Albania 5
AM - Armenia 5
CL - Cile 5
KG - Kirghizistan 5
NZ - Nuova Zelanda 5
RO - Romania 5
DO - Repubblica Dominicana 4
GR - Grecia 4
HU - Ungheria 4
IL - Israele 4
SY - Repubblica araba siriana 4
BG - Bulgaria 3
DK - Danimarca 3
ET - Etiopia 3
KW - Kuwait 3
KZ - Kazakistan 3
MY - Malesia 3
OM - Oman 3
PE - Perù 3
BY - Bielorussia 2
DZ - Algeria 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
LB - Libano 2
LK - Sri Lanka 2
MT - Malta 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
RS - Serbia 2
SN - Senegal 2
SO - Somalia 2
TT - Trinidad e Tobago 2
UG - Uganda 2
UY - Uruguay 2
Totale 22.277
Città #
Southend 1.712
Dallas 1.060
Fairfield 878
Dublin 784
Menlo Park 730
Singapore 730
Ashburn 643
Chandler 554
Woodbridge 400
Santa Clara 380
Milan 371
Siena 371
Moscow 361
Jacksonville 347
Wilmington 332
San Jose 329
Seattle 311
Houston 305
Cambridge 276
Beijing 266
Hong Kong 260
Ann Arbor 238
Hefei 202
Seoul 168
Council Bluffs 164
Princeton 164
Los Angeles 141
New York 125
The Dalles 122
Ho Chi Minh City 120
Nanjing 116
Helsinki 111
Florence 106
Rome 98
Hanoi 83
Lauterbourg 83
Boardman 75
Munich 71
Johannesburg 66
San Mateo 59
Columbus 54
Shanghai 52
São Paulo 52
Buffalo 51
Bengaluru 47
Dearborn 47
London 46
San Diego 46
Fremont 45
Nanchang 44
Brussels 40
Abidjan 39
Izmir 38
Orem 37
Lancaster 34
Shenyang 32
Frankfurt am Main 30
Abuja 29
Málaga 28
Figino 27
Haiphong 27
Warsaw 26
Tianjin 25
Atlanta 24
Da Nang 24
Stockholm 24
Chicago 23
Tokyo 23
Hebei 22
Changsha 21
Phoenix 21
Redwood City 21
Brno 20
Denver 20
Amsterdam 19
Norwalk 19
Chennai 18
Jiaxing 18
Boston 17
Brooklyn 17
Montreal 17
Redondo Beach 17
Vienna 17
Zhengzhou 17
Dong Ket 16
Kunming 16
Rio de Janeiro 16
Belo Horizonte 15
Hangzhou 15
Manchester 15
Poplar 15
Renton 15
Turin 15
Turku 15
San Francisco 14
Toronto 14
Düsseldorf 13
Nuremberg 13
Jakarta 12
Monteroni D'arbia 12
Totale 15.258
Nome #
Chondroptosis in alkaptonuric cartilage 493
A new integrated and interactive tool applicable to inborn errors of metabolism: Application to alkaptonuria 490
Amyloidosis, Inflammation, and Oxidative Stress in the Heart of an Alkaptonuric Patient 429
4-Hydroxyphenylpyruvate Dioxygenase and Its Inhibition in Plants and Animals: Small Molecules as Herbicides and Agents for the Treatment of Human Inherited Diseases 417
Homogentisic acid induces morphological and mechanical aberration of ochronotic cartilage in alkaptonuria 412
Biochemical and proteomic characterization of alkaptonuric chondrocytes 399
Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria. 382
Histological and Ultrastructural Characterization of Alkaptonuric Tissues 377
Smoothened-antagonists reverse homogentisic acid-induced alterations of Hedgehog signaling and primary cilium length in alkaptonuria 369
Effects of Nitisinone on Oxidative and Inflammatory Markers in Alkaptonuria: Results from SONIA1 and SONIA2 Studies 362
Beer promotes differentiation and mineralization of human osteoblastic cells: Role of silicon 359
Establishment of Four New Human Primary Cell Cultures from Chemo-Naïve Italian Osteosarcoma Patients 358
Alkaptonuria is a novel human secondary amyloidogenic disease 354
Inflammatory and oxidative stress biomarkers in alkaptonuria: data from the DevelopAKUre project 351
Angiogenesis in alkaptonuria 349
Diagnosis of secondary amyloidosis in alkaptonuria 312
Homogentisate 1,2 dioxygenase is expressed in human osteoarticular cells: implications in alkaptonuria. 308
Different factors affecting human ANP amyloid aggregation and their implications in congestive heart failure 308
Yield Determination of Bioethanol Production of Saccharomyces Cerevisiae Metabolic Process by Mathematical Modelling and In-Vivo 13C-NMR 303
Cytoskeleton Aberrations in Alkaptonuric Chondrocytes 302
Comparative proteomics in alkaptonuria provides insights into inflammation and oxidative stress 297
Homogentisic acid induces aggregation and fibrillation of amyloidogenic proteins 291
Inhibition of para-Hydroxyphenylpyruvate Dioxygenase by Analogues of the Herbicide Nitisinone As a Strategy to Decrease Homogentisic Acid Levels, the Causative Agent of Alkaptonuria 290
Amyloidosis in alkaptonuria 289
An Introduction to Personalized Nutrition 288
Wild-type wine Saccharomyces cerevisiae as a tool to evaluate the effects on eukaryotic life of locally used herbicides 286
Proteomic and redox-proteomic evaluation of homogentisic acid and ascorbic acid effects on human articular chondrocytes 284
Machine learning application for development of a data-driven predictive model able to investigate quality of life scores in a rare disease 281
Interactive alkaptonuria database: investigating clinical data to improve patient care in a rare disease 279
Secondary amyloidosis in an alkaptonuric aortic valve 275
Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosis 272
Homogentisic acid induces autophagy alterations leading to chondroptosis in human chondrocytes: Implications in Alkaptonuria 272
Comparative analysis of the effects of locally used herbicides and their active ingredients on a wild-type wine Saccharomyces cerevisiae strain 270
Machine learning application for patient stratification and phenotype/genotype investigation in a rare disease 269
Redox-proteomics of the effects of homogentisic acid in an in vitro human serum model of alkaptonuric ochronosis 267
Homogentisate 1,2 dioxygenase is expressed in brain: implications in alkaptonuria 266
Antibacterial activity of grape extracts towards cagA positive and cagA negative Helicobacter pylori clinical isolates 266
Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial 264
Oxidative stress and mechanisms of ochronosis in alkaptonuria 263
Saccharomyces cerevisiae as a Tool to Evaluate the Effects of Herbicides on Eukaryotic Life 262
Mapping phosphoproteins in Neisseria meningitidis serogroup A 260
Helicobacter pylori: immunoproteomics related to different pathologies 251
Oxidative damage mediated by herbicides on yeast cells 249
Alkaptonuria 248
Proteomics and redox-proteomics of the effects of herbicides on a wild-type wine Saccharomyces cerevisiae strain 243
Prevalence of isolated atrial amyloidosis in young patients affected by congestive heart failure 241
Foodomics for human health: current status and perspectives 238
Suitability of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment 237
Redox proteomics gives insights into the role of oxidative stress in alkaptonuria 235
Effects of selenium on oxidative damage and antioxidant enzymes of eukaryotic cells: wine Saccharomyces cerevisiae 234
Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model 228
In vivo NMR study of yeast fermentative metabolism in the presence of ferric irons 226
Metabolic response to exogenous ethanol in yeast: an in vivo NMR and mathematical modelling approach 223
Helicobacter pylori immunoproteomes in case reports of rosacea and chronic urticaria 217
Oxidative damage induced by herbicides is mediated by thiol oxidation and hydroperoxides production 213
Supportive use of cyclodextrins as decontamination agents for herbicides 213
Membrane Skeletal Protein S-Glutathionylation in Human Red Blood Cells as Index of Oxidative Stress 212
Cell and tissue models of alkaptonuria 211
Post-genomics of bone metabolic dysfunctions and neoplasias 210
Personalized nutrition and omics technologies 206
Expanding the proteome database of Meningococcus A 202
Omics Perspectives in Food Science 201
Saccharomyces cerevisiae as a model in ecotoxicological studies: a post-genomics perspective 200
Omics-based technologies for food authentication and traceability 199
Postgenomics of Neisseria meningitidis: An update 196
Surfome analysis of a wild-type wine Saccharomyces cerevisiae strain 192
Bacterial post-genomics approaches for vaccines development 191
Sub-lethal ethanol exposure enhances viability and ethanol production in Saccharomyces cerevisiae 187
Linking protein oxidation to environmental pollutants: redox proteomic approaches 182
Omics and rare diseases: challenges, applications, and future perspectives 178
Post-genomics and skin inflammation 178
Alkaptonuria: From Molecular Insights to a Dedicated Digital Platform 177
The therapy for Helicobacter pylori eradication 175
Rubus ulmifolius Leaf Extract Inhibits Proliferation of Murine Myeloma Cells 163
Diagnosis of Helicobacter pylori infection 163
Homogentisic acid is not only eliminated by glomerular filtration and tubular secretion but also produced in the kidney in alkaptonuria 160
Leveraging proteomics in orphan disease research: pitfalls and potential 159
The analysis of Neisseria meningitidis proteomes: reference maps and their applications 154
Identification of Helicobacter pylori proteins involved in metronidazole resistance by comparative proteomic analysis 151
Postgenomics of Neisseria meningitidis for vaccines development 151
Post-genomics of Neisseria meningitidis: an update 142
Proteomics in plant research 134
Survey on the recent advances in 4-Hydroxyphenylpyruvate Dioxygenase (HPPD) inhibition by diketone and triketone derivatives and congeneric compounds: structural analysis of HPPD/inhibitor complexes and structure-activity relationship considerations 134
Kinetics of different processes in human ANP amyloid formation 132
Helicobacter pylori infection and extra-digestive diseases 128
Models of rare diseases 125
Helicobacter pylori VacA and CagA virulence factors 124
Novel identification of expressed genes and functional classification of hypothetical proteins from Neisseria meningitidis serogroup A 123
Subclinical ochronosis features in alkaptonuria: a cross-sectional study 123
A Comprehensive In Vitro and In Silico Approach for Targeting 4-Hydroxyphenyl Pyruvate Dioxygenase: Towards New Therapeutics for Alkaptonuria 99
Uncovering proteomic and biochemical alterations in plasma from Lesch–Nyhan disease patients 82
Destabilization of Helix III Initiates Early Serum Amyloid A Misfolding by Exposing Its Amyloidogenic Core 67
Integrated Clinomics and Molecular Dynamics Simulation Approaches Reveal the SAA1.1 Allele as a Biomarker in Alkaptonuria Disease Severity 13
Totale 22.545
Categoria #
all - tutte 62.942
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.942


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.447 0 173 118 121 77 62 83 60 86 193 161 313
2022/20231.822 117 188 236 249 167 340 61 155 167 43 54 45
2023/20241.357 47 30 126 65 66 361 427 38 5 14 48 130
2024/20252.657 64 136 328 136 295 132 128 180 258 115 261 624
2025/20267.152 453 884 886 862 1.364 253 771 172 254 352 198 703
2026/2027316 284 32 0 0 0 0 0 0 0 0 0 0
Totale 22.545